Discovery to Commercialization: New Immunotherapy for Rare Childhood Cancer, Neuroblastoma
Name
Excellence in Technology Transfer
From
Federal Laboratory Consortium (FLC)
Type
National Award
Year
2016
ICs
NCI
Applications
Therapeutics
![FLC Logo](/sites/default/files/styles/content/public/2024-03/flc_logo_0.png?itok=rhhzPk9F)